Polarean Imaging plc (FRA:8ZF)

Market Cap	1.54M
Revenue (ttm)	2.18M
Net Income (ttm)	-8.17M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0005 - 0.0200
Beta	n/a
RSI	47.76
Earnings Date	Dec 24, 2025

About Polarean Imaging

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest...

• Industry: Laboratory Apparatus and Furniture
• Founded: 2016
• Employees: 26
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8ZF

Financial Performance

In 2024, Polarean Imaging's revenue was $3.09 million, an increase of 246.82% compared to the previous year's $890,933. Losses were -$8.54 million, -28.14% less than in 2023.

Financial numbers in USD